SCHEMBL8880481

SCHEMBL8880481

N#CC(CC1CCN(Cc2ccccc2)CC1)(c1ccccc1)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
KCNA3 P22001 4/20 0.64
CCR3 P51677 3/20 0.61
CHRM3 P20309 4/20 0.53
CHRM2 P08172 2/20 0.53
CHRM1 P11229 2/20 0.53
ACHE P22303 2/20 0.50
ALDH1A1 P00352 1/20 0.50
CXCR4 P61073 1/20 0.50
BCHE P06276 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL10719501 0.83 BCHE (0.49) KCNA3CCR3ACHEBCHE
Hydrochloric Acid SCHEMBL10718577 0.83 KCNA3 (0.54) KCNA3CCR3CHRM3CHRM2CHRM1
SCHEMBL10519952 0.79 CCR3 (0.59) CCR3CHRM3CHRM2CHRM1ACHE
SCHEMBL803462 0.79 CCR3 (0.67) CCR3ACHEALDH1A1CXCR4BCHE
SCHEMBL4186493 0.78 KCNA3 (0.55) KCNA3CCR3CHRM3CHRM2CHRM1
SCHEMBL6749208 0.78 CCR3 (0.54) CCR3ACHEALDH1A1CXCR4BCHE
SCHEMBL4757519 0.78 KCNA3 (0.54) KCNA3CCR3CHRM3CHRM2CHRM1
SCHEMBL3975039 0.78 CHRM3 (0.69) KCNA3CCR3CHRM3CHRM2CHRM1
SCHEMBL12794683 0.78 CHRM3 (0.69) KCNA3CCR3CHRM3CHRM2CHRM1
SCHEMBL10316373 0.78 CHRM3 (0.69) KCNA3CCR3CHRM3CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607950-A IRRITABLE BOWEL SYNDROME PFIZER INC. (US) 1997-03-04 US disclosed
EP-0508988-B1 MUSCARINIC RECEPTOR ANTAGONISTS PFIZER LTD (GB) 1994-03-02 EP disclosed
EP-0508988-A1 MUSCARINIC RECEPTOR ANTAGONISTS. PFIZER LTD (GB) 1992-10-21 EP disclosed
WO-1991010647-A1 MUSCARINIC RECEPTOR ANTAGONISTS PFIZER LIMITED (GB) 1991-07-25 WO disclosed